MDCG Guidance on Qualification and Classification of Annex XVI Products: Overview and Qualification | EU Source Cluster: Reg Desk Source Node: 2542990Time Stamp: Apr 12, 2024
HSA Guidance on Medical Device Product Registration: Specific Aspects | HSA Source Cluster: Reg Desk Source Node: 2542992Time Stamp: Apr 12, 2024
SFDA Guidance on Surgical Sutures: Overview | SFDA Source Cluster: Reg Desk Source Node: 2543032Time Stamp: Apr 12, 2024
SFDA Guidance on In-House IVDs: Overview | SFDA Source Cluster: Reg Desk Source Node: 2543035Time Stamp: Apr 12, 2024
SFDA Guidance on In-House IVDs: Intended Use and Risks | SFDA Source Cluster: Reg Desk Source Node: 2544108Time Stamp: Apr 12, 2024
Health Canada Guidance on Management of Medical Device Applications: Review Process | RegDesk Source Cluster: Reg Desk Source Node: 2544110Time Stamp: Apr 12, 2024
SFDA Guidance on In-House IVDs: Specific Aspects | SFDA Source Cluster: Reg Desk Source Node: 2547585Time Stamp: Apr 12, 2024
IMDRF Guide on Adverse Event Reporting Terminology: Overview | RegDesk Source Cluster: Reg Desk Source Node: 2547587Time Stamp: Apr 12, 2024
IMDRF Guide on Adverse Event Reporting Terminology: Details | RegDesk Source Cluster: Reg Desk Source Node: 2548688Time Stamp: Apr 12, 2024
TGA Guidance on Conformity Assessment Certification Applications | TGA Source Cluster: Reg Desk Source Node: 2548690Time Stamp: Apr 12, 2024
FDA Draft Guidance on Section 524B: Overview | United States Source Cluster: Reg Desk Source Node: 2538795Time Stamp: Apr 8, 2024
FDA Draft Guidance on Section 524B: Documentation | United States Source Cluster: Reg Desk Source Node: 2538797Time Stamp: Apr 8, 2024
FDA Draft Guidance on Section 524B: Specific Aspects | United States Source Cluster: Reg Desk Source Node: 2539641Time Stamp: Apr 8, 2024
TGA Consultation on CDSS Software Regulation: Overview | TGA Source Cluster: Reg Desk Source Node: 2539643Time Stamp: Apr 8, 2024
TGA Consultation on CDSS Software Regulation: Problems and Proposals | TGA Source Cluster: Reg Desk Source Node: 2541780Time Stamp: Apr 8, 2024
FDA Draft Guidance on Q-Submission Program: Overview | United States Source Cluster: Reg Desk Source Node: 2541782Time Stamp: Apr 8, 2024
MDCG Guidance on Content of Clinical Investigation Plan: Specific Aspects | EU Source Cluster: Reg Desk Source Node: 2533827Time Stamp: Apr 1, 2024
Health Canada Guidance on Management of Medical Device Applications: Overview | RegDesk Source Cluster: Reg Desk Source Node: 2533829Time Stamp: Apr 1, 2024
DRAP Draft Guidance on Clinical Research: Final Reporting | Pakistan Source Cluster: Reg Desk Source Node: 2517377Time Stamp: Mar 14, 2024
Health Canada Guidance on Medical Device Recalls: Overview | RegDesk Source Cluster: Reg Desk Source Node: 2517379Time Stamp: Mar 14, 2024